{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:39:50Z","timestamp":1791614390136,"version":"4.3.4"},"reference-count":33,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:00:00Z","timestamp":1571875200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JHD"],"published-print":{"date-parts":[[2019,10,24]]},"DOI":"10.3233\/jhd-190382","type":"journal-article","created":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T14:11:53Z","timestamp":1569593513000},"page":"421-430","source":"Crossref","is-referenced-by-count":13,"title":["Positive Attitudes and Therapeutic Misconception Around Hypothetical Clinical Trial Participation in the Huntington\u2019s Disease Community"],"prefix":"10.1177","volume":"8","author":[{"given":"Kristina","family":"Cotter","sequence":"first","affiliation":[{"name":"Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly E.","family":"Siskind","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon J.","family":"Sha","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea K.","family":"Hanson-Kahn","sequence":"additional","affiliation":[{"name":"Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA"},{"name":"Department of Pediatrics, Division of Medical Genetics, Stanford University Medical Center, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"4","key":"10.3233\/JHD-190382_ref1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: Natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.3233\/JHD-190382_ref2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington\u2019s disease: A clinical review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.3233\/JHD-190382_ref3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3233\/JHD-170262","article-title":"Clinical trials corner: September 2017","volume":"6","author":"Rodrigues","year":"2017","journal-title":"J Huntingtons Dis"},{"issue":"R1","key":"10.3233\/JHD-190382_ref4","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1093\/hmg\/ddv442","article-title":"Gene suppression strategies for dominantly inherited neurodegenerative diseases: Lessons from Huntington\u2019s disease and spinocerebellar ataxia","volume":"25","author":"Keiser","year":"2016","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.3233\/JHD-190382_ref5","first-page":"38","article-title":"Sustained therapeutic reversal of Huntington\u2019s disease by transient repression of huntingtin synthesis","volume":"13","author":"Abeliovich","year":"2013","journal-title":"Nat Rev Neurosci"},{"issue":"24","key":"10.3233\/JHD-190382_ref6","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","article-title":"Targeting huntingtin expression in patients with Huntington\u2019s disease","volume":"380","author":"Tabrizi","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.3233\/JHD-190382_ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-014-1339-0","article-title":"Factors associated with willingness to participate in clinical trials: A nationwide survey study","volume":"15","author":"Chu","year":"2015","journal-title":"BMC Public Health"},{"issue":"6","key":"10.3233\/JHD-190382_ref8","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2796.1999.00502.x","article-title":"Ethical aspects of clinical trials: The attitudes of the public and out- patients","volume":"245","author":"Madsen","year":"1999","journal-title":"J Intern Med"},{"issue":"5","key":"10.3233\/JHD-190382_ref9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1445-5994.2011.02433.x","article-title":"Attitudes and views of the general public towards research participation","volume":"43","author":"Burns","year":"2013","journal-title":"Intern Med J"},{"issue":"11","key":"10.3233\/JHD-190382_ref10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2016-013649","article-title":"Cross-sectional assessment of patient attitudes towards participation in clinical trials: Does making results publicly available matter?","volume":"6","author":"Jones","year":"2016","journal-title":"BMJ Open"},{"issue":"6","key":"10.3233\/JHD-190382_ref11","first-page":"748","article-title":"Therapeutic misconception in research subjects: Development and validation of a measure","volume":"9","author":"Appelbaum","year":"2012","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.3233\/JHD-190382_ref12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1369-6513.1999.00028.x","article-title":"Attitudes to randomized clinical trials amongst out-patients attending a medical oncology clinic","volume":"2","author":"Ellis","year":"1999","journal-title":"Health Expect"},{"issue":"1","key":"10.3233\/JHD-190382_ref13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2307\/3564408","article-title":"Misunderstanding in clinical research: Distinguishing therapeutic misconception, therapeutic misestimation, & therapeutic optimism","volume":"25","author":"Horng","year":"2003","journal-title":"IRB Ethics Hum Res"},{"issue":"8","key":"10.3233\/JHD-190382_ref14","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/medethics-2015-103319","article-title":"Are patients with amyotrophic lateral sclerosis at risk of a therapeutic misconception?","volume":"42","author":"Kim","year":"2016","journal-title":"J Med Ethics"},{"issue":"2","key":"10.3233\/JHD-190382_ref15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/13607863.2011.602962","article-title":"Development and initial validation of the Therapeutic Misunderstanding Scale for use with clinical trials research participants","volume":"16","author":"Chou","year":"2012","journal-title":"Aging Ment Health"},{"issue":"5","key":"10.3233\/JHD-190382_ref16","first-page":"7","article-title":"An approach to evaluating therapeutic misconception","volume":"31","author":"Kim","year":"2009","journal-title":"IRB Ethics Hum Res"},{"issue":"1","key":"10.3233\/JHD-190382_ref17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12913-017-2090-x","article-title":"Clinical trials from the patient perspective: Survey in an online patient community","volume":"17","author":"DasMahapatra","year":"2017","journal-title":"BMC Health Serv Res"},{"issue":"444","key":"10.3233\/JHD-190382_ref18","first-page":"1","article-title":"Clinical features of Parkinson\u2019s disease patients are associated with therapeutic misconception and willingness to participate in clinical trials","volume":"18","author":"Reijula","year":"2017","journal-title":"Trials"},{"issue":"1","key":"10.3233\/JHD-190382_ref19","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.nurt.2008.10.002","article-title":"Poster 1: Survey of clinical trial interest and literacy in Huntington support groups: Northwest pilot project","volume":"6","author":"Veatch Goodman","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.3233\/JHD-190382_ref20","first-page":"1","article-title":"Attitudes of potential participants towards molecular therapy trials in Huntington\u2019s disease","volume":"8","author":"Bardakjian","year":"2019","journal-title":"J Huntingtons Dis"},{"issue":"5","key":"10.3233\/JHD-190382_ref21","first-page":"1","article-title":"Longitudinal study of informed consent in innovative therapy research: Experience and provisional recommendations from a multicenter trial of intracerebral grafting","volume":"10","author":"De Langavant","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.3233\/JHD-190382_ref22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/mds.27247","article-title":"Predictive testing and clinical trials in Huntington\u2019s disease: An ethical analysis: Ethics Of Testing in HD Trials","volume":"33","author":"Sampaio","year":"2018","journal-title":"Mov Disord"},{"issue":"1","key":"10.3233\/JHD-190382_ref23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ajmg.b.32453","article-title":"Genetic counseling and testing for Huntington\u2019s disease: A historical review","volume":"174","author":"Nance","year":"2017","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"10","key":"10.3233\/JHD-190382_ref24","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/ejhg.2016.36","article-title":"22 Years of predictive testing for Huntington\u2019s disease: The experience of the UK Huntington\u2019s Prediction Consortium","volume":"24","author":"Baig","year":"2016","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"10.3233\/JHD-190382_ref25","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1369-7625.2005.00335.x","article-title":"Patient attitudes to clinical trials: Development of a questionnaire and results from asthma and cancer patients","volume":"8","author":"Jenkinson","year":"2005","journal-title":"Health Expect"},{"key":"10.3233\/JHD-190382_ref26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.seizure.2018.06.006","article-title":"Comparable indicators of therapeutic misconception between epilepsy or Parkinson\u2019s disease patients between those with clinical trial experience and trial non-participants","volume":"60","author":"Reijula","year":"2018","journal-title":"Seizure"},{"issue":"2015","key":"10.3233\/JHD-190382_ref27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.yebeh.2015.05.013","article-title":"Therapeutic misconception correlates with willingness to participate in clinical drug trials among patients with epilepsy; need for better counseling","volume":"48","author":"Reijula","year":"2015","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.3233\/JHD-190382_ref28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1369-7625.2005.00335.x","article-title":"Patient attitudes to clinical trials: Development of a questionnaire and results from asthma and cancer patients","volume":"8","author":"Jenkinson","year":"2005","journal-title":"Health Expect"},{"key":"10.3233\/JHD-190382_ref29","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1089\/hum.2005.16.1028","article-title":"Confronting the issues of therapeutic misconception, enrollment decisions, and personal motives in genetic medicine-based clinical research studies for fatal disorders","volume":"16","author":"Arkin","year":"2005","journal-title":"Hum Gene Ther"},{"issue":"4","key":"10.3233\/JHD-190382_ref30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jagp.2012.11.009","article-title":"Decision making for participation in dementia research","volume":"21","author":"Black","year":"2013","journal-title":"Am J Geriatr Psychiatry"},{"issue":"4","key":"10.3233\/JHD-190382_ref31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jagp.2012.11.014","article-title":"\u201cThinking about it for somebody else\u201d: Alzheimer\u2019s disease research and proxy decision makers\u2019 translation of ethical principles into practice","volume":"21","author":"Dunn","year":"2013","journal-title":"Am J Geriatr Psychiatry"},{"issue":"7","key":"10.3233\/JHD-190382_ref32","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/journalofethics.2017.19.7.nlit1-1707","article-title":"When does therapeutic misconception affect surrogates\u2019 or subjects\u2019 decision making about whether to participate in dementia research?","volume":"19","author":"Dunn","year":"2017","journal-title":"AMA J Ethics"},{"issue":"5","key":"10.3233\/JHD-190382_ref33","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1176\/appi.ajp.158.5.712","article-title":"Assessing the competence of persons with Alzheimer\u2019s for participation in research","volume":"158","author":"Scott","year":"2001","journal-title":"Am J Psychiatry"}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JHD-190382","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:50:56Z","timestamp":1777452656000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JHD-190382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,24]]},"references-count":33,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jhd-190382","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,24]]}}}